CAS 929622-08-2

Fórmula: C19H27N3O2

InChI: InChI=1S/C19H27N3O2/c23-19(22-9-7-21(8-10-22)18-5-6-18)17-3-1-16(2-4-17)15-20-11-13-24-14-12-20/h1-4,18H,5-15H2

Chave InChI: BGBVSGSIXIIREO-UHFFFAOYSA-N

SMILES: C1CC1N2CCN(CC2)C(=O)C3=CC=C(C=C3)CN4CCOCC4

Bavisant

CAS: 929622-08-2

Fórmula: C₁₉H₂₇N₃O₂

Pureza: 99%

Peso molecular: 329.4366

Ref: IN-DA00GU1D

Bavisant

CAS: 929622-08-2

Bavisant

Fórmula: C₁₉H₂₇N₃O₂

Pureza: ≥95%

Peso molecular: 329.44

Ref: 54-BUP12735

Bavisant

CAS: 929622-08-2

Bavisant is a serotonin receptor antagonist. This drug has been used in the diagnosis of serotonin-related disorders, such as depression and anxiety. Bavisant has also been used to treat hyperactivity and attention deficit hyperactivity disorder (ADHD) in children. The drug is administered orally, with a dose of 0.5 mg/kg per day for up to 5 days. Bavisant interacts with h2-receptor antagonists, which may lead to decreased gastric acidity and increased absorption of other drugs, such as warfarin or cimetidine. In clinical trials, the drug has shown statistically significant improvements in treatment effect on ADHD symptoms in children when compared to placebo groups. It is hypothesized that Bavisant's pharmacological effects are due to its ability to block serotonin receptors and reduce the synthesis of dopamine by inhibiting the enzyme tyrosine hydroxylase.

Fórmula: C₁₉H₂₇N₃O₂

Pureza: Min. 95%

Peso molecular: 329.4 g/mol

Ref: 3D-EMB62208

Bavisant

CAS: 929622-08-2

Bavisant (JNJ-31001074) is a selective and orally active Human H3 receptor antagonist.

Fórmula: C₁₉H₂₇N₃O₂

Pureza: 99.21% - 99.65%

Cor e Forma: Solid

Peso molecular: 329.44

Ref: TM-TQ0046